Latest presentation

First quarter 2019 results

Tromsø, Norway, 30 April 2019 – Biotec Pharmacon (OSE: Biotec) announces its Q1 2019 results to 31 March 2019. Highlights for Q1 2019 Group sales were up 4% to NOK 14.8 million (Q1 2018: NOK 14.2 million). Gross profit for the Group improved 23% to NOK 12.0 million (Q1 2018: NOK 9.7…

View more